28205591|t|Protective Effect of 17beta-Estradiol Upon Hippocampal Spine Density and Cognitive Function in an Animal Model of Vascular Dementia.
28205591|a|The current study examined whether the steroid hormone, 17beta-estradiol (E2) can exert long-lasting beneficial effects upon axonal health, synaptic plasticity, dementia-related amyloid-beta (Abeta) protein expression, and hippocampal-dependent cognitive function in an animal model of chronic cerebral hypoperfusion and vascular dementia (VaD). Chronic cerebral hypoperfusion and VaD was induced by bilateral common carotid artery occlusion (BCCAO) in adult male Sprague Dawley rats. Low dose E2 administered for the first 3-months after BCCAO exerted long-lasting beneficial effects, including significant neuroprotection of hippocampal CA1 neurons and preservation of hippocampal-dependent cognitive function when examined at 6-months after BCCAO. E2 treatment also prevented BCCAO-induced damage to hippocampal myelin sheaths and oligodendrocytes, enhanced expression of the synaptic proteins synaptophysin and PSD95 in the hippocampus, and prevented BCCAO-induced loss of total and mushroom dendritic spines in the hippocampal CA1 region. Furthermore, E2-treatment also reduced BCCAO induction of dementia-related proteins expression such as p-tau (PHF1), total ubiquitin, and Abeta1-42, when examined at 6 m after BCCAO. Taken as a whole, the results suggest that low-dose E2 replacement might be a potentially promising therapeutic modality to attenuate or block negative neurological consequences of chronic cerebral hypoperfusion and VaD.
28205591	21	37	17beta-Estradiol	Chemical	MESH:D004958
28205591	43	54	Hippocampal	Disease	MESH:D000092223
28205591	114	131	Vascular Dementia	Disease	MESH:D015140
28205591	172	187	steroid hormone	Chemical	MESH:D013256
28205591	189	205	17beta-estradiol	Chemical	MESH:D004958
28205591	207	209	E2	Chemical	MESH:D004958
28205591	294	302	dementia	Disease	MESH:D003704
28205591	356	367	hippocampal	Disease	MESH:D000092223
28205591	419	449	chronic cerebral hypoperfusion	Disease	MESH:D006521
28205591	454	471	vascular dementia	Disease	MESH:D015140
28205591	473	476	VaD	Disease	MESH:D015140
28205591	479	509	Chronic cerebral hypoperfusion	Disease	MESH:D006521
28205591	514	517	VaD	Disease	MESH:D015140
28205591	543	574	common carotid artery occlusion	Disease	MESH:D002340
28205591	576	581	BCCAO	Disease	MESH:D002340
28205591	612	616	rats	Species	10116
28205591	627	629	E2	Chemical	MESH:D004958
28205591	672	677	BCCAO	Disease	MESH:D002340
28205591	760	771	hippocampal	Disease	MESH:D000092223
28205591	804	815	hippocampal	Disease	MESH:D000092223
28205591	877	882	BCCAO	Disease	MESH:D002340
28205591	884	886	E2	Chemical	MESH:D004958
28205591	912	917	BCCAO	Disease	MESH:D002340
28205591	936	947	hippocampal	Disease	MESH:D000092223
28205591	1088	1093	BCCAO	Disease	MESH:D002340
28205591	1153	1164	hippocampal	Disease	MESH:D000092223
28205591	1190	1192	E2	Chemical	MESH:D004958
28205591	1216	1221	BCCAO	Disease	MESH:D002340
28205591	1235	1243	dementia	Disease	MESH:D003704
28205591	1353	1358	BCCAO	Disease	MESH:D002340
28205591	1412	1414	E2	Chemical	MESH:D004958
28205591	1541	1571	chronic cerebral hypoperfusion	Disease	MESH:D006521
28205591	1576	1580	VaD.	Disease	MESH:D015140
28205591	Negative_Correlation	MESH:D004958	MESH:D003704
28205591	Negative_Correlation	MESH:D004958	MESH:D006521
28205591	Negative_Correlation	MESH:D004958	MESH:D000092223
28205591	Negative_Correlation	MESH:D004958	MESH:D015140
28205591	Negative_Correlation	MESH:D004958	MESH:D002340

